Fistuloclysis Improves Liver Function and Nutritional Status in Patients with High-Output Upper Enteric Fistula

Table 1

Demographics and clinical characteristics of the two groups.

Characteristics	Fistuloclysis (𝑛=35)	Control (𝑛=60)	𝑃 value
Age (years)	50.2±14.1	55.8±11.2	0.687
Male, 𝑛 (%)	24 (68.6)	37 (61.7)	0.650
BMI (kg/m^2)	19.1±3.5	19.7±2.3	0.627
Scores on admission
APACHE II (24 h)	11.5±3.0	12.2±2.6	0.208
SOFA (24 h)	4.5±1.2	4.8±1.1	0.071
Etiology, 𝑛 (%)
Trauma	14 (40.0)	22 (36.7)	0.747
Tumor	3 (8.6)	7 (11.7)	0.637
Ischemic enteropathy	1 (2.9)	1 (1.7)	0.698
Operations	10 (28.6)	13 (21.7)	0.449
Pancreatitis	5 (14.3)	8 (13.3)	0.897
IBD	2 (5.7)	9 (15.0)	0.175
Fistula locations, 𝑛 (%)
Jejunal-ileal	11 (31.4)	20 (33.3)	0.849
Biliary	16 (45.7)	3 (5.0)	𝟎.𝟎𝟒𝟐^∗
Duodenal	8 (22.9)	37 (61.7)	𝟎.𝟎𝟑𝟑^∗
Underlying disease, 𝑛 (%)
Cancer	6 (17.1)	7 (11.7)	0.456
Cardiovascular disease	2 (5.7)	2 (3.3)	0.579
Diabetes	4 (11.4)	2 (3.3)	0.120
COPD	6 (17.1)	12 (20.0)	0.732
None	18 (51.4)	37 (61.7)	0.330
Charges ($), mean ± SD	30215.1±6518.9	44261.3±5631.2	<𝟎.𝟎𝟎𝟏^∗
Hospital stay (days), mean ± SD	56.2±24.3	74.6±19.8	<𝟎.𝟎𝟎𝟏^∗
Hospital mortality, 𝑛 (%)	0 (0)	5 (8.3)	𝟎.𝟎𝟐𝟓^∗

BMI: body mass index; APACHE II: acute physiology score and chronic health evaluation II; SOFA: sequential organ failure assessment score; IBD: inflammatory bowel disease; COPD: chronic obstructive pulmonary disease. Data were presented as mean ± SD. 𝑃 value < 0.05 was deemed significant.